hGPR65
Nomenclature
C57BL/6JSmo-Gpr65tm(hGPR65)Smoc
Cat. NO.
NM-HU-220504
Strain State
Repository Live
Gene Summary
Gene Symbol
Gpr65
Model Description
Validation Data

Fig.1 Detection of Gpr65 expression in spleen and lung by RT-PCR. Mouse Gpr65 mRNA (846 bp) was detectable both in wild-type C57BL/6 mice. Human GRB14 mRNA (259 bp) was detectable only in homozygous hGPR65 knock-in mice but not in wild-type mice. Spleen and lung RNA was extracted from 6-week-old male wild-type C57BL/6 mice (n=2) and 9-week-old female homozygous hGPR65 knock-in mice (n=2), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mRNA primers.
Abbr. M, marker; HO, homozygous; WT, wild type.

Fig.2 Detection of GPR65 expression in hGPR65 knock-in mice by WB. GPR65 was detectable in liver and kidney from both WT C57BL/6 and HO hGPR65 knock-in mice using a cross-actived antibody recognizing human and mouse GPR65 and specific bands were detected for GPR65 at approximately 37 kDa (as indicated). The liver and kidney tissue lysates were collected from 6-week-old male wild-type C57BL/6 mice and 9-week-old female homozygous hGPR65 knock-in mice, and then analyzed by western blot with anti-GPR65 antibody.
Abbr. HO, homozygous; WT, wild type.

Fig.3 Detection of GPR65 expression in hGPR65 knock-in mice by WB. GPR65 was detectable in kidney and lung tissues from both WT C57BL/6 and HO hGPR65 mice using a cross-actived antibody recognizing the extracellular fragment of human and mouse GPR65, and specific bands were detected for GPR65 between 70–100 kDa, which might be caused by different post-translational modifications. The kidney, lung and spleen tissue lysates were collected from 8-week-old male wild-type C57BL/6 mice and 8-week-old male homozygous hGPR65 knock-in mice, and then analyzed by western blot with anti-GPR65 antibody.
Abbr. HO, homozygous; WT, wild type.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more